At The Nexus Group, we know that anxiety interferes with daily life and can leave you searching for new solutions. As mental health treatments continue to evolve, you might wonder if Spravato® is approved for anxiety.
This medication has gained attention for its role in treating depression—but what about other conditions? Let us explain what Spravato is, what it is approved to treat, and whether it may be an option if you are experiencing anxiety.
What Is Spravato?
Spravato (esketamine) is an FDA-approved prescription nasal spray derived from ketamine. Unlike traditional antidepressants, which may take weeks to show results, Spravato can act quickly, sometimes within hours or days. It must be given under the supervision of a health care provider in a certified treatment center, such as The Nexus Group. Although approved for TRD, Spravato may positively affect anxiety.
What Is Spravato FDA Approved To Treat?
Currently, the FDA has approved Spravato for two conditions: treatment-resistant depression—for adults who have tried two or more antidepressants without enough improvement—and major depressive disorder with suicidal thoughts or actions—for adults experiencing severe depressive symptoms with urgent need for intervention.
These approvals highlight Spravato’s role as a treatment for depression, not anxiety.
Is Spravato Approved To Treat Anxiety?
Spravato is not FDA-approved to treat anxiety disorders. While ongoing research is exploring whether esketamine may help with conditions such as generalized anxiety disorder or social anxiety disorder, it has not yet received official approval for these uses.
That means if you are seeking Spravato specifically for anxiety, insurance providers are unlikely to cover it unless depression is also part of your diagnosis.
However, if you are diagnosed with MDD and TRD, you may also experience overlapping symptoms of anxiety, such as excessive worry, restlessness, or panic attacks. In these cases, treatment with Spravato for depression may also reduce the severity of anxiety-related symptoms.
Researchers continue to investigate Spravato’s potential for primary anxiety disorders, and future FDA approvals may expand its use. For now, the focus remains on its approved role in treating MDD and TRD.
What Are the Alternatives for Anxiety Treatment?
If anxiety is your main concern, there are several effective treatment options available. Traditional anti-anxiety medications or antidepressants can target anxiety disorders and reduce symptoms.
Cognitive behavioral therapy and other evidence-based approaches may be effective in helping you address anxiety symptoms. Lifestyle strategies, such as exercise, sleep support, and mindfulness, can complement professional care.
At The Nexus Group, we may consider transcranial magnetic stimulation when depression and anxiety symptoms overlap, especially when you do not respond to medications alone.
Our providers can work with you to design a personalized plan that best fits your needs.
How Do You Know if Spravato or Another Treatment Is Right for You?
The best way to determine if Spravato is approved for your symptoms and is the right choice is to schedule an appointment. During your appointment, we can review your medical history and explore your past experiences with medications and therapy.
We can evaluate if you meet the criteria to receive Spravato and discuss effective alternative treatments when needed. By carefully considering your unique situation, we guide you toward treatment that offers the best chance for relief.
Call Us To Determine if Spravato Is Approved for Your Anxiety
If you have been struggling with anxiety or depression and are wondering about Spravato, The Nexus Group is here to help. While Spravato is not approved specifically for anxiety, our expert providers can help you explore all available treatment options.
Contact us at The Nexus Group today to schedule your appointment and discover if Spravato could work for you.
